FDA compounder NDC directory
Browse every current FDA compounder source row, including records that do not contain a usable NDC.
Compounder NDC directory#
Every current compounder source row is browsable, including records whose FDA source did not provide a usable product, package, or lookup NDC. Browse the unified current auxiliary catalog. · Browse the complete captured source and snapshot history.
| Establishment | FEI | Product NDC | Package NDC | Brand | Nonproprietary name | Active ingredients | Period | Normalization | Source date |
|---|---|---|---|---|---|---|---|---|---|
| Hybrid Pharma | 079665742 | 26436-5433 | 26436-5433-1 | Benzocaine; Tetracaine; Lidocaine | 200 mg/1 g; 40 mg/1 g; 80 mg/1 g | 2024-2 | valid | 2026-10-13 | |
| Hybrid Pharma | 26436-5433 | 26436-5433-1 | BLT DMSO Gel | BLT 20/8/4 DMSO | 200 mg/1 g; 40 mg/1 g; 80 mg/1 g | 2024-2 | valid | 2026-09-18 | |
| Hybrid Pharma | 079665742 | 26436-5433 | 26436-5433-1 | Benzocaine; Tetracaine; Lidocaine | 200 mg/1 g; 40 mg/1 g; 80 mg/1 g | 2024-1 | valid | 2026-10-13 | |
| Hybrid Pharma | 079665742 | 26436-5433 | 26436-5433-1 | Benzocaine; Tetracaine; Lidocaine | 200 mg/1 g; 40 mg/1 g; 80 mg/1 g | 2021-2 | valid | 2026-10-13 | |
| Hybrid Pharma | 079665742 | 26436-5433 | 26436-5433-1 | Tetracaine; Lidocaine; Benzocaine | 40 mg/1 g; 80 mg/1 g; 200 mg/1 g | 2020-2 | valid | 2026-10-13 |